diclofenac has been researched along with Koch's Disease in 4 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to ascertain whether DCL used in combination with the first-line antitubercular antibiotic streptomycin (STM) synergistically augments its efficacy in vitro as well as in a murine tuberculosis infection model." | 7.74 | Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. ( Dastidar, SG; Dutta, NK; Mazumdar, K; Park, JH, 2007) |
| " The aim of this study was to ascertain whether DCL used in combination with the first-line antitubercular antibiotic streptomycin (STM) synergistically augments its efficacy in vitro as well as in a murine tuberculosis infection model." | 3.74 | Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. ( Dastidar, SG; Dutta, NK; Mazumdar, K; Park, JH, 2007) |
| "The effects of half-sized secretory leukocyte protease inhibitor or diclofenac sodium administered alone or in combination with the benzoxazinorifamycin KRM-1648 on the therapeutic efficacy of KRM-1648 against Mycobacterium avium complex (MAC) in mice were studied." | 1.30 | Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infection i ( Kawahara, S; Kawauchi, H; Sano, C; Sato, K; Shimizu, T; Tomioka, H, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutta, NK | 1 |
| Mazumdar, K | 1 |
| Dastidar, SG | 1 |
| Park, JH | 1 |
| Akaki, T | 1 |
| Sato, K | 2 |
| Shimizu, T | 2 |
| Tomioka, H | 2 |
| Kawahara, S | 2 |
| Sano, C | 1 |
| Kawauchi, H | 1 |
| O'brien, WM | 1 |
4 other studies available for diclofenac and Koch's Disease
| Article | Year |
|---|---|
Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Disease Models, | 2007 |
[In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti | 1997 |
Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infection i
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antitubercular; Cytokines; Diclofenac | 1999 |
Adverse reactions to nonsteroidal anti-inflammatory drugs. Diclofenac compared with other nonsteroidal anti-inflammatory drugs.
Topics: Aged; Anaphylaxis; Anemia, Aplastic; Anti-Inflammatory Agents; Asthma; Blood Platelets; Chemical and | 1986 |